Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

760039

544619

SUDEEPPHRM

img img img img
No Data Available

Sudeep Pharma Limited performance

Today’s low

Today’s high

₹ 593.15 ₹ 645.00
₹ 597.30

52 week low

52 week high

₹ 543.90 ₹ 795.00
₹ 597.30

Open Price

₹ 623.95

Prev. Close

₹ 601.40

Volume (Shares)

1195360.00

Total traded value

₹ 7139.88

Upper Circuit

₹ 661.50

Lower Circuit

₹ 541.30

info

Sudeep Pharma Limited Share Price Update

As of the latest trading session, Sudeep Pharma Limited share price is currently at ₹ 621.4, which is up by ₹ 20.00 from its previous closing. Today, the stock has fluctuated between ₹ 593.15 and ₹ 645.00. Over the past year, Sudeep Pharma Limited has achieved a return of [-] %. In the last month alone, the return has been -18.40 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Sudeep Pharma Limited fundamentals


  • Market cap (Cr)

    6,725.50

  • P/E Ratio (TTM)

    70.84

  • Beta

    1.94

  • Book Value / share

    46.41

  • Return on equity

    25.12%

  • EPS (TTM)

    8.47

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    29.74

info icon alternate text
  • Market cap (Cr)

    6,918.10

  • P/E Ratio (TTM)

    70.84

  • Beta

    1.81

  • Book Value / share

    46.41

  • Return on equity

    25.12%

  • EPS (TTM)

    8.47

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    29.74

info icon alternate text

Sudeep Pharma Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 87.88
Operating Expense 60.81
Net Profit 29.74
Net Profit Margin (%) 33.84
Earnings Per Share (EPS) 2.67
EBITDA 43.70
Effective Tax Rate (%) 25.46
Particulars JUN 2025 (Values in Cr)
Revenue 80.17
Operating Expense 52.97
Net Profit 25.20
Net Profit Margin (%) 31.43
Earnings Per Share (EPS) 2.29
EBITDA 37.01
Effective Tax Rate (%) 25.48
Particulars SEP 2024 (Values in Cr)
Revenue 106.30
Operating Expense 68.27
Net Profit 29.45
Net Profit Margin (%) 27.70
Earnings Per Share (EPS) 2.71
EBITDA 41.64
Effective Tax Rate (%) 25.36
Particulars JUN 2024 (Values in Cr)
Revenue 62.10
Operating Expense 0.00
Net Profit 12.53
Net Profit Margin (%) 20.17
Earnings Per Share (EPS) 3.29
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 356.73
Operating Expense 235.70
Net Profit 95.75
Net Profit Margin (%) 26.84
Earnings Per Share (EPS) 8.82
EBITDA 140.34
Effective Tax Rate (%) 26.01
Particulars MAR 2025 (Values in Cr)
Book Value / Share 50.48
ROE % 32.76
ROCE % 35.54
Total Debt to Total Equity 0.25
EBITDA Margin 39.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 2526.42
ROE % 37.42
ROCE % 41.24
Total Debt to Total Equity 0.22
EBITDA Margin 41.06
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1159.15
ROE % 36.15
ROCE % 35.69
Total Debt to Total Equity 0.41
EBITDA Margin 21.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 810.48
ROE % 34.17
ROCE % 35.43
Total Debt to Total Equity 0.26
EBITDA Margin 22.09
Particulars MAR 2020 (Values in Cr)
Book Value / Share 574.46
ROE % 22.29
ROCE % 25.01
Total Debt to Total Equity 0.25
EBITDA Margin 23.26
Particulars MAR 2025 (Values in Cr)
Book Value / Share 44.01
ROE % 25.12
ROCE % 28.51
Total Debt to Total Equity 0.24
EBITDA Margin 39.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 2374.56
ROE % 34.32
ROCE % 38.66
Total Debt to Total Equity 0.23
EBITDA Margin 41.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1681.07
ROE % 33.16
ROCE % 34.81
Total Debt to Total Equity 0.35
EBITDA Margin 24.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1193.96
ROE % 36.81
ROCE % 36.98
Total Debt to Total Equity 0.36
EBITDA Margin 22.10
Particulars MAR 2021 (Values in Cr)
Book Value / Share 822.76
ROE % 35.54
ROCE % 36.73
Total Debt to Total Equity 0.26
EBITDA Margin 22.70
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 51.80
Total Assets 717.17
Total Liabilities 717.17
Total Equity 493.09
Share Outstanding 97227890
Price to Book Ratio 0.00
Return on Assets (%) 19.34
Return on Capital (%) 22.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.97
Total Assets 513.86
Total Liabilities 513.86
Total Equity 355.99
Share Outstanding 1409100
Price to Book Ratio 0.00
Return on Assets (%) 25.92
Return on Capital (%) 30.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 21.47
Total Assets 343.80
Total Liabilities 343.80
Total Equity 163.33
Share Outstanding 1409100
Price to Book Ratio 0.00
Return on Assets (%) 14.59
Return on Capital (%) 20.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.95
Total Assets 212.70
Total Liabilities 212.70
Total Equity 114.20
Share Outstanding 1409100
Price to Book Ratio 0.00
Return on Assets (%) 15.67
Return on Capital (%) 22.95
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 4.09
Total Assets 130.83
Total Liabilities 130.83
Total Equity 80.94
Share Outstanding 1409100
Price to Book Ratio 0.00
Return on Assets (%) 13.78
Return on Capital (%) 18.4
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 45.34
Total Assets 604.09
Total Liabilities 604.09
Total Equity 430.11
Share Outstanding 97227890
Price to Book Ratio 0.00
Return on Assets (%) 15.84
Return on Capital (%) 17.45
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.59
Total Assets 450.59
Total Liabilities 450.59
Total Equity 334.59
Share Outstanding 1409100
Price to Book Ratio 0.00
Return on Assets (%) 21.76
Return on Capital (%) 24.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.35
Total Assets 416.02
Total Liabilities 416.02
Total Equity 236.87
Share Outstanding 1409100
Price to Book Ratio 0.00
Return on Assets (%) 16.14
Return on Capital (%) 21.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 14.87
Total Assets 333.16
Total Liabilities 333.16
Total Equity 168.24
Share Outstanding 1409100
Price to Book Ratio 0.00
Return on Assets (%) 15.69
Return on Capital (%) 21.71
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.19
Total Assets 213.81
Total Liabilities 213.81
Total Equity 115.93
Share Outstanding 1409100
Price to Book Ratio 0.00
Return on Assets (%) 16.36
Return on Capital (%) 23.8
Particulars MAR 2025 (Values in Cr)
Net Income 182.84
Cash from Operations 89.27
Cash from Investing -78.75
Cash from Financing 52.69
Net change in Cash 22.66
Free Cash Flow 153.50
Particulars MAR 2024 (Values in Cr)
Net Income 174.81
Cash from Operations 110.43
Cash from Investing -49.28
Cash from Financing -12.73
Net change in Cash 3.66
Free Cash Flow 162.89
Particulars MAR 2022 (Values in Cr)
Net Income 68.60
Cash from Operations 14.59
Cash from Investing -38.41
Cash from Financing 50.91
Net change in Cash 9.51
Free Cash Flow 88.21
Particulars MAR 2021 (Values in Cr)
Net Income 43.02
Cash from Operations 45.87
Cash from Investing -40.41
Cash from Financing 12.99
Net change in Cash 7.85
Free Cash Flow 57.56
Particulars MAR 2020 (Values in Cr)
Net Income 24.60
Cash from Operations 15.91
Cash from Investing -22.47
Cash from Financing 12.44
Net change in Cash -0.15
Free Cash Flow 25.11
Particulars MAR 2025 (Values in Cr)
Net Income 129.40
Cash from Operations 88.82
Cash from Investing -91.59
Cash from Financing 54.19
Net change in Cash 21.75
Free Cash Flow 149.90
Particulars MAR 2024 (Values in Cr)
Net Income 132.30
Cash from Operations 95.27
Cash from Investing -40.66
Cash from Financing -16.14
Net change in Cash 2.24
Free Cash Flow 127.09
Particulars MAR 2023 (Values in Cr)
Net Income 90.77
Cash from Operations 64.09
Cash from Investing -40.71
Cash from Financing -10.11
Net change in Cash -8.52
Free Cash Flow 102.45
Particulars MAR 2022 (Values in Cr)
Net Income 70.40
Cash from Operations 11.73
Cash from Investing -27.96
Cash from Financing 39.97
Net change in Cash 6.67
Free Cash Flow 68.66
Particulars MAR 2021 (Values in Cr)
Net Income 44.95
Cash from Operations 46.39
Cash from Investing -44.71
Cash from Financing 12.99
Net change in Cash 4.09
Free Cash Flow 58.08
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.45 13.46 1.42 210.36 25.97 / 57.00
BLISS GVS PHARMA LTD 175.20 16.91 1.63 1853.42 105.05 / 195.85
CIPLA LTD 1466.15 21.77 3.59 118431.38 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 328.00 8.62 2.46 965.34 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.45 22.32 3.82 210.36 25.97 / 57.00
AMRUTAJAN HEALTH LTD 627.45 32.00 5.30 1814.00 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 8327.35 90.05 26.05 20818.38 6501.60 / 10653.05
BLISS GVS PHARMA LTD 175.20 23.64 1.67 1853.42 105.05 / 195.85

Sudeep Pharma Limited shareholding pattern

Holding

4.57%
76.15%
1.67%
17.59%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Sudeep Pharma Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
595.45 -0.98 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 582.80
  • 26 Days 634.00
  • 10 Days 593.20
  • 50 Days 646.90
  • 12 Days 598.20
  • 100 Days 646.90
  • 20 Days 618.00
  • 200 Days 646.90
553.85 PIVOT

First Support

536.80

First Resistance

563.80

Second Support

526.85

Second Resistance

580.85

Third Support

509.80

Third Resistance

590.80

RSI

15.31

ADX

40.71

MACD

-39.05

Williams % R

-97.80

Commodity Channel Index (CCI)

-145.33

Date

2026-01-09

Week

103896.00

Same Day

85398.00

Month

101299.00

1 Year

1.47

3 Year

1.52

Over 1 Month

-18.40%

down

Over 1 Year

0.00%

down

Over 3 Months

-29.37%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Sudeep Pharma Limited Corporate Actions

Top Gainers

Sudeep Pharma Limited Share Price

Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited' as a private limited company dated December 21, 1989, issued by the Registrar of Companies, Ahmedabad. Thereafter, Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli. Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of Company was accordingly changed from Sudeep Pharma Limited' to Sudeep Pharma Private Limited'. Further, Company was converted into a public limited company and consequently, the name of Company was changed to Sudeep Pharma Limited'.

The Company is one of the pioneers in India to introduce a product range of liposomal ingredients for nutrient absorption and stability. The Company is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries. It operate three manufacturing facilities in Vadodara, Gujarat with an annual installed capacity of 65, 579 MT.

Since inception in 1989, Company has expanded business operations from production of excipients to a wide variety of over 100 products in the pharmaceutical, food and nutrition industries. Business is primarily structured into two verticals: Pharmaceutical, food and nutrition and Specialty ingredients. The Company focus on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries.. Many of these minerals act as excipients, supporting the efficacy and stability of pharmaceutical formulations. Specialty ingredients entails production of customized ingredients to improve functionality, stability, and bioavailability across food and nutraceutical
applications. These specialty ingredients play a key role in enhancing nutritional profiles, texture, and flavour across applications such as fortified dairy, beverages, and bakery products, as well as dietary supplements.

Company is planning to launch the initial public offer by raising funds of Rs 95 Crore equity shares through fresh issue and by issuing 10,076,492
equity shares, having the face value of Rs 1/- each via offer for sale.

Parent organization Indian Private
NSE symbol SUDEEPPHRM
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sudeep Pharma Ltd?

Answer Field

Sudeep Pharma Ltd share price is for NSE ₹ 621.40 & for BSE ₹ 613.65 as on Jan 13 2026 03:30 PM.

What is the Market Cap of Sudeep Pharma Ltd Share?

Answer Field

The market cap of Sudeep Pharma Ltd for NSE ₹ 6,041.74 & for BSE ₹ 5,966.39 as on Jan 13 2026 03:30 PM.

What is the 52 Week High and Low of Sudeep Pharma Ltd?

Answer Field

The 52 Week High and Low of Sudeep Pharma Ltd for NSE is ₹ 795.00 and ₹ 543.90 and for BSE is ₹ 795.80 and ₹ 540.50.

What is 1 year return for Sudeep Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Sudeep Pharma Ltd Share?

Answer Field

As on Jan 13 2026 03:30 PM the price-to-earnings (PE) ratio for Sudeep Pharma Ltd share is 70.84.

What is the PB ratio of Sudeep Pharma Ltd Share?

Answer Field

As on Jan 13 2026 03:30 PM, the price-to-book (PB) ratio for Sudeep Pharma Ltd share is 46.41.

How to Buy Sudeep Pharma Ltd Share?

Answer Field

You can trade in Sudeep Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sudeep Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Sudeep Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sudeep Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59